Skip to search formSkip to main contentSkip to account menu

Extended Release Oral Capsule

Known as: Extended-release capsule, Capsule, extended release, XR Cap 
A capsule designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
IPX066 (extended‐release carbidopa‐levodopa [ER CD‐LD]) is an oral extended‐release capsule formulation of carbidopa and levodopa… 
Review
2013
Review
2013
Pierre Fabre and Forest Laboratories are developing levomilnacipran extended release (ER) [FETZIMA™], an enantiomer of… 
2013
2013
OBJECTIVE To describe the novel use of high-dose insulin (HDI) therapy and intravenous lipid emulsion (ILE) to treat refractory… 
2010
2010
Several matrix tablet formulations (hydrophilic-based, wax-based, and three-layer tablets) were designed for controlling the… 
2008
2008
Dissolution methods are different for extended-release mesalamine capsules (pH 7.5 only) and delayed-release tablets (pH 1.4, 6.0… 
Review
2007
Review
2007
Both positron emission tomography and single photon emission computed tomography (SPECT) studies suggest that saturation of… 
Highly Cited
2002
Highly Cited
2002
OBJECTIVE SLI381 (Adderall XR) is a 2-component extended-release capsule formulation of Adderall designed to produce a…